7 vs 14 Days of Antibiotics for Bacteremia, Factor XI Inhibition for Atrial Fibrillation, ACEi or ARB Before Elective Surgery, GLP-1 Agonist for HFpEF and Obesity

7 vs 14 Days of Antibiotics for Bacteremia, Factor XI Inhibition for Atrial Fibrillation, ACEi or ARB Before Elective Surgery, GLP-1 Agonist for HFpEF and Obesity

From Last Week in Medicine by Stephen Jenkins, MD, Austin Rupp, MD

February 7, 2025 · 1h 6m · Episode 59

About this episode

The episode discusses various medical topics including the duration of antibiotic therapy for bacteremia and the use of Factor XI inhibitors in atrial fibrillation.

We're back, after a brief hiatus! Today we talk about duration of therapy for bacteremia, Factor XI inhibition for atrial fibrillation, whether to stop ACEi or ARB before elective surgery, and whether GLP-1 agonists are beneficial in heart failure with preserved ejection fraction. Go to minute 7:30 to skip the banter. 7 vs 14 Days of Antibiotics for Bacteremia (BALANCE) Abelacimab vs Rivaroxaban for Atrial Fibrillation (AZALEA-TIMI-71) Asenduxian vs Apixaban for Atrial Fibri...

People in this episode

Hosts: Stephen Jenkins, MD, Austin Rupp, MD

Topics covered

  • bacteremia treatment duration
  • Factor XI inhibition
  • ACEi or ARB before surgery
  • GLP-1 agonists
  • heart failure with preserved ejection fraction
  • atrial fibrillation

Keywords

  • bacteremia
  • antibiotics
  • Factor XI
  • atrial fibrillation
  • ACEi
  • ARB
  • GLP-1 agonists
  • heart failure
  • obesity

Mentioned in this episode

Products: Abelacimab, Rivaroxaban, Asenduxian, Apixaban

More episodes of Last Week in Medicine

Explore listener stats, chart rankings, contacts and more on the Last Week in Medicine podcast page.